Skip to main content

Table 1 Colon cancer patients versus healthy individuals.

From: Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer

  

Healthy Controls

(n = 10)

Colon Ca patients

(n = 16)

Age

51, 8

55, 18

Sex

Male

8 (%80)

12(%75)

 

Female

2(%20)

4(%25)

  1. Age and sex distribution of metastatic colon cancer patients (n = 16) and healthy control individuals (n = 10)